Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 11
Submit an article Journal homepage
195
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Carboxypeptidase-G 2 Rescue in Cancer Patients with Delayed Methotrexate Elimination after High-dose Methotrexate Therapy

Anke S. Krause Department for Internal Medicine I, University of Cologne, Cologne, Germany
,
Martin R. Weihrauch Department for Internal Medicine I, University of Cologne, Cologne, Germany
,
Udo Bode Department of Pediatrics, University of Bonn, Bonn, Germany
,
Gudrun Fleischhack Department of Pediatrics, University of Bonn, Bonn, Germany
,
Thomas Elter Department for Internal Medicine I, University of Cologne, Cologne, Germany
,
Theodor Heuer St. Franziskus Hospital Mönchengladbach, Mönchengladbach, Germany
,
Andreas Engert Department for Internal Medicine I, University of Cologne, Cologne, Germany
,
Volker Diehl Department for Internal Medicine I, University of Cologne, Cologne, Germany
&
Andreas Josting Department for Internal Medicine I, University of Cologne, Cologne, Germany
 show all
Pages 2139-2143 | Published online: 01 Jul 2009

  • Goldin, A., Venditti, J.M. and Kline, I. (1966) "Eradication of leukaemic cells (L1210) by methotrexate and methotrexate plus citrovorum factor", Nature 212, 1548-1550.
  • Josting, A., Dichl, V. and Engert, A. (1998) "Methotrexatpharmakologie. Toxizitact und rescue-massnahmen bei hochdosierter behandlung", Onkologe 4, 974-985.
  • Allegra, C.J. (1999) "Antifolates: the next millennium", Semin. Oncol. 26, 1-2.
  • Abelson, H.T., Fosburg, M.T., Beardsley, G.P., Goorin, A.M., Gorka, C.,. Link, M. and Link, D. (1983) "Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine", J. Clin. Oncol. 1, 208-216.
  • Condit, P.T., Chanes, R.E. and Joel, W. (1969) "Renal toxicity of methotrexate", Cancer 23, 126-131.
  • Jacobs, S.A., Stoller, R.G., Chabner, B.A. and Johns, D.G. (1976) "7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate", J. Clin. Investis. 57, 534-538
  • Pinedo, H.M., Zaharko, D.S., Bull, J.M. and Chabner, B.A. (1976) "The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides", Cancer Res. 36, 4418-4424.
  • Ahmad, S., Shen, F.H. and Bleyer, W.A. (1978) "Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis", Arch. Intern. Med. 138, 1146-1147.
  • Relling, M.V., Stapleton, R.B., Ochs,. J., Jones, D.P., Meyer, W., Wainer, I.W., Crom, W.R., McKay, C.P. and Evans, W.E. (1988) "Removal of methotrexate. leucovorin. and their metabolites by combined hemodialysis and hemoperfusion", Cancer 62, 884-888.
  • Molina, R., Fabian, C. and Cowley, Jr. B. (1987) "Use of charcoal hemoperfusion with sequential hemodialysis to reduce serum methotrexate levels in a patient with acute renal insufficiency", Am. J. Med. 82, 350-352.
  • Zoubek, A., Zaunschirm, H.A., Lion, T., Fischmeister, G., Vollnhofer, G., Gadner, H., Pillwein, K., Schalhorn, A. and Bode, U. (1995) "Successful carboxypeptidase G2 rescue in delayed methotrexate elimination due to renal failure", Pediatr. Hematol. Oncol. 12, 471-477.
  • Widemann, B.C., Balis, F.M., Murphy, R.F., Sorensen, J.M., Montello, M.J., O'Brien, M. and Adamson, P.C. (1997) "Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction", J. Clin. Oncol. 15, 2125-2134.
  • Widemann, B.C. Hetherington, M.L., Murphy, R.F., Balis, F.M. and Adamson, P.C. (1995) "Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity", Cancer 76, 521-526.
  • von Poblozki, A., Dempke, W. and Schmoll, H.J. (2000) "Carboxypeptidase-G2-rescue in a woman with methotrexate-induced renal failure", Med Klin. 95, 457-460.
  • Albrecht, A.M., Boldizsar, E. and Hutchison, D.J. (1978) "Carboxypeptidase displaying differential velocity in hydrolysis of methotrexate, 5-methyltetrahydrofolic acid, and leucovorin", J. Bacterial. 134, 506-513.
  • McCullough, J.L., Chabner, B.A. and Bertino, J.R. (1971) "Purification and properties of carboxypeptidase G.I., J. Biol. Chem. 246, 7207-7213.
  • Minton, N.P., Atkinson, T. and Sherwood, R.F. (1983) "Molecular cloning of the Pseudomonas carboxypeptidase G2 gene and its expression in Escherichia coli and Pseudomonas putida", J. Bacteriol. 156, 1222-1227.
  • Sherwood, R.F., Melton, R.G., Alwan, S.M. and Hughes, P. (1985) "Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS-16. Use of a novel triazine dye affinity method", Eur. J. Biochem. 148, 447-453.
  • Adamson, P.C., Balis, F.M., McCully, C.L., Godwin, K.S. and Poplack, D.G. (1992) "Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys", J. Clin. Oncol. 10, 1359-1364.
  • Josting, A., Rudolph, C., Mapara, M., Ko, Y., Soehngen, D., Doerken, B., Diehl, V. and Engert, A. (2001) "Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin's disease and aggressive non-Hodgkin's lymphoma--results of a multicenter phase II study", Blood 98, 2848a.
  • Pels, H., Deckert-Schluter, M., Glasmacher, A., Kleinschmidt, R., Oehring, R., Fischer, H.P., Bode, U. and Schlegel, U. (2000) "Primary central nervous system lymphoma: a clinicopathological study of 28 cases", Hematol. Oncol. 18, 21-32.
  • Hoelzer, D. and Gokbuget, N. (2000) "New approaches tu acute lymphoblastic leukemia in adults: where do we go?", Semin. Oncol. 27, 540-559.
  • Bielack, S., Kempf-Bielack, B., Schwenzer, D., Birkfellner, T., Delling, G., Ewerbeck, V., Exner, G.U., Fuchs, N., Gobel, U., Graf, N., Heise, U., Helmke, K., von Hochstetter, A.R., Jurgens, H., Maas, R., Munchow, N., Salzer-Kuntschik, M., Treuner, J., Veltmann, U., Werner, M., Winkelmann, W., Zoubek, A. and Kotz, R. (1999) "Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients", Klin. Padiatr. 211, 260-270.
  • Sauer, H. and Schalhorn, A. (1980) "Radiational basis and practice of the citrovorum factor (Leucovorin) protection after high-dose methotrexate therapy. High-dose methotrexate/leucovorin", Onkologie 3, 64-71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.